Diagonal Bio (Sweden) Price Prediction
| DIABIO Stock | 0.03 0 4.98% |
Oversold Vs Overbought
54
Oversold | Overbought |
Using Diagonal Bio hype-based prediction, you can estimate the value of Diagonal Bio AB from the perspective of Diagonal Bio response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Diagonal Bio to buy its stock at a price that has no basis in reality. In that case, they are not buying Diagonal because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Diagonal Bio after-hype prediction price | SEK 0.03 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Diagonal |
Diagonal Bio After-Hype Price Prediction Density Analysis
As far as predicting the price of Diagonal Bio at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Diagonal Bio or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Diagonal Bio, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Diagonal Bio Estimiated After-Hype Price Volatility
In the context of predicting Diagonal Bio's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Diagonal Bio's historical news coverage. Diagonal Bio's after-hype downside and upside margins for the prediction period are 0.00 and 21.88, respectively. We have considered Diagonal Bio's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Diagonal Bio is out of control at this time. Analysis and calculation of next after-hype price of Diagonal Bio AB is based on 3 months time horizon.
Diagonal Bio Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Diagonal Bio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Diagonal Bio backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Diagonal Bio, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.90 | 21.85 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.03 | 0.03 | 1.64 |
|
Diagonal Bio Hype Timeline
Diagonal Bio AB is currently traded for 0.03on Stockholm Exchange of Sweden. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Diagonal is forecasted to decline in value after the next headline, with the price expected to drop to 0.03. The average volatility of media hype impact on the company price is insignificant. The price decline on the next news is expected to be -1.64%, whereas the daily expected return is currently at 1.9%. The volatility of related hype on Diagonal Bio is about 0.0%, with the expected price after the next announcement by competition of 0.03. About 15.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.5. Some equities with similar Price to Book (P/B) outperform the market in the long run. Diagonal Bio AB recorded a loss per share of 1.83. The entity had not issued any dividends in recent years. The firm had 175:103 split on the 25th of November 2022. Assuming the 90 days trading horizon the next forecasted press release will be in a few days. Check out Diagonal Bio Basic Forecasting Models to cross-verify your projections.Diagonal Bio Related Hype Analysis
Having access to credible news sources related to Diagonal Bio's direct competition is more important than ever and may enhance your ability to predict Diagonal Bio's future price movements. Getting to know how Diagonal Bio's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Diagonal Bio may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| AZN | AstraZeneca PLC | 0.00 | 0 per month | 0.00 | (0.26) | 1.86 | (3.06) | 9.94 | |
| INVE-A | Investor AB ser | 0.00 | 0 per month | 0.00 | (0.16) | 1.40 | (1.40) | 4.28 | |
| INVE-B | Investor AB ser | 0.00 | 0 per month | 0.00 | (0.15) | 1.35 | (1.33) | 4.71 | |
| ATCO-B | Atlas Copco AB | 0.00 | 0 per month | 0.00 | (0.13) | 2.40 | (1.78) | 8.09 | |
| ATCO-A | Atlas Copco AB | 0.00 | 0 per month | 0.00 | (0.13) | 2.14 | (1.96) | 8.48 | |
| NDA-SE | Nordea Bank Abp | 0.00 | 0 per month | 0.98 | (0.09) | 1.92 | (1.65) | 8.28 | |
| VOLV-B | AB Volvo | 0.00 | 0 per month | 1.13 | (0.08) | 2.82 | (1.88) | 7.55 | |
| VOLV-A | AB Volvo | 0.00 | 0 per month | 0.00 | (0.1) | 2.59 | (2.18) | 7.85 | |
| HEXA-B | Hexagon AB | 0.00 | 0 per month | 0.00 | (0.17) | 2.99 | (3.14) | 7.78 |
Diagonal Bio Additional Predictive Modules
Most predictive techniques to examine Diagonal price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Diagonal using various technical indicators. When you analyze Diagonal charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Diagonal Bio Predictive Indicators
The successful prediction of Diagonal Bio stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Diagonal Bio AB, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Diagonal Bio based on analysis of Diagonal Bio hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Diagonal Bio's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Diagonal Bio's related companies.
Story Coverage note for Diagonal Bio
The number of cover stories for Diagonal Bio depends on current market conditions and Diagonal Bio's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Diagonal Bio is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Diagonal Bio's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Diagonal Bio Short Properties
Diagonal Bio's future price predictability will typically decrease when Diagonal Bio's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Diagonal Bio AB often depends not only on the future outlook of the potential Diagonal Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Diagonal Bio's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 9.1 M | |
| Cash And Short Term Investments | 20.8 M |
Complementary Tools for Diagonal Stock analysis
When running Diagonal Bio's price analysis, check to measure Diagonal Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Diagonal Bio is operating at the current time. Most of Diagonal Bio's value examination focuses on studying past and present price action to predict the probability of Diagonal Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Diagonal Bio's price. Additionally, you may evaluate how the addition of Diagonal Bio to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Transaction History View history of all your transactions and understand their impact on performance |